HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brita Singers Sørensen Selected Research

Nimorazole

6/2020Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy.
9/2016Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials.
9/2013Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.
1/2012Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brita Singers Sørensen Research Topics

Disease

13Neoplasms (Cancer)
10/2022 - 09/2011
11Hypoxia (Hypoxemia)
06/2020 - 08/2005
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021 - 09/2009
4Squamous Cell Carcinoma of Head and Neck
06/2020 - 09/2011
3Head and Neck Neoplasms (Head and Neck Cancer)
09/2018 - 09/2011
2Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 08/2018
2Oropharyngeal Neoplasms
06/2020 - 01/2014
2Neoplasm Metastasis (Metastasis)
08/2018 - 01/2014
1Fibrosis (Cirrhosis)
10/2022
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
10/2022
1Rectal Neoplasms (Rectal Cancer)
09/2022
1Inflammation (Inflammations)
10/2020
1Exanthema (Rash)
09/2018
1Hodgkin Disease (Hodgkin's Disease)
12/2015
1Acidosis
01/2015
1Lung Neoplasms (Lung Cancer)
08/2013
1Lymphatic Metastasis
08/2013
1Starvation
09/2009

Drug/Important Bio-Agent (IBA)

5Oxygen (Dioxygen)IBA
01/2015 - 08/2005
4Cell-Free Nucleic AcidsIBA
09/2022 - 08/2018
4NimorazoleIBA
06/2020 - 01/2012
4Formaldehyde (Formol)FDA Link
10/2016 - 01/2012
4ParaffinIBA
10/2016 - 01/2012
3Protons (Proton)IBA
10/2022 - 01/2018
3Proteins (Proteins, Gene)FDA Link
12/2015 - 09/2009
2DNA (Deoxyribonucleic Acid)IBA
07/2021 - 01/2020
2Nucleic AcidsIBA
01/2018 - 08/2013
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2014 - 08/2013
1CytokinesIBA
10/2020
1Epidermal Growth Factor (EGF)IBA
09/2018
1zalutumumabIBA
09/2018
1Irinotecan (Camptosar)FDA LinkGeneric
08/2018
1IonsIBA
01/2018
1Becaplermin (PDGF-BB)FDA Link
12/2016
1Interleukin-2 (IL2)IBA
12/2016
1Interleukin-4 (Interleukin 4)IBA
12/2016
1Interleukin-6 (Interleukin 6)IBA
12/2016
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2016
1Interleukin-8 (Interleukin 8)IBA
12/2016
1Plasminogen Activator Inhibitor 1IBA
12/2016
1Interleukin-13IBA
12/2016
1LeptinIBA
12/2016
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
12/2016
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016
1MicroRNAs (MicroRNA)IBA
02/2016
1Lactic Acid (Lactate)FDA LinkGeneric
01/2015
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2015
1Protein Isoforms (Isoforms)IBA
01/2015
1Adenosine Triphosphate (ATP)IBA
01/2015
1Peptide Initiation Factors (Initiation Factor)IBA
01/2015
1CarbonIBA
01/2014
1RNA (Ribonucleic Acid)IBA
08/2013
1ProteomeIBA
09/2009

Therapy/Procedure

8Radiotherapy
10/2020 - 09/2011
4Therapeutics
01/2018 - 01/2012
2Aftercare (After-Treatment)
10/2022 - 11/2014
2Chemoradiotherapy
09/2022 - 06/2020
1Neoadjuvant Therapy
09/2022
1Heavy Ion Radiotherapy
01/2018